Priority Date: 27.12.11 (CU 20110000245)

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMOURS THAT EXPRESS WGFR AND GANGLIOSIDE N-GLYCOLYL GM3(NEUGCGM3)

  • Application ID: EP12806334
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1916
Headquarter in The Hague and 9 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Vereenigde Octrooibureaux NV (V.O.) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 188 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 27.12.2011 - Priority Date (CU 20110000245)
  • 04.07.2013 - Publication A1 (WO2013097834)
  • 26.11.2014 - Publication A1 (EP2805747)